In a European cohort of 53 consecutive WD patients, 60% of patients presented with chronic liver disease showed elevated ALT [53], 11-13% of the patients showed elevated bilirubin at the time of diagnosis, and approximately 10% reported a history of clinically overt jaundice [54, 55]. This evidence concerns the gene GPT and Wilson disease.